US Broker Ratings

Agilent Technologies, Inc. (A) Stock Analysis: 23.5% Potential Upside and Strong Buy Ratings Propel Investor Interest

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector’s diagnostics and research industry, is capturing investor attention with its promising potential upside and..

CVS Health Corporation (CVS) Stock Analysis: Navigating a 2.49% Potential Upside Amid Solid Buy Ratings

For investors with a keen eye on the healthcare sector, CVS Health Corporation (NYSE: CVS) presents a compelling opportunity. With a market capitalization of $130.09 billion,..

UnitedHealth Group (UNH) Stock Analysis: Navigating Growth Amidst a Stable Dividend Yield

UnitedHealth Group Incorporated (NYSE: UNH) stands out as a formidable player in the healthcare sector, with a commanding market capitalization of $371 billion. Operating primarily in..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a Potential 25% Upside in Healthcare Innovation

Investors keeping a close watch on IQVIA Holdings, Inc. (NYSE: IQV) might find it hard to overlook the significant potential upside of 25.07% suggested by the..

ResMed Inc. (RMD) Stock Analysis: Exploring a Potential 38.93% Upside in the Healthcare Innovator

ResMed Inc. (NYSE: RMD), a prominent player in the Healthcare sector, is capturing the attention of investors with its promising financials and a significant potential upside...

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 16.52% Upside Potential with Strong Buy Ratings

Labcorp Holdings Inc. (NYSE: LH) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring a 12.22% Potential Upside

Fresenius Medical Care AG (NYSE: FMS) stands as a pivotal player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bad Homburg,..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring the 22% Upside Potential

For investors seeking growth opportunities in the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) presents an intriguing proposition. With a market capitalization of $29.65 billion,..

Cardinal Health, Inc. (CAH)

⚠️ No article content returned.

..

DexCom, Inc. (DXCM) Stock Analysis: Exploring a 13% Potential Upside in the Healthcare Sector

DexCom, Inc. (NASDAQ: DXCM), a prominent player in the medical devices industry, presents an intriguing opportunity for investors keen on the healthcare sector. With its focus..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare Opportunities with a $32.19 Billion Market Cap

Centene Corporation (NYSE: CNC), a formidable player in the healthcare plans industry, commands a market capitalization of $32.19 billion. This positions the company as a significant..

STERIS plc (STE) Investor Outlook: Exploring a 23.75% Potential Upside in the Medical Devices Sector

Investors eyeing the healthcare sector’s robust growth potential may find STERIS plc (STE) an intriguing prospect. With a market cap of $20.23 billion, STERIS plc stands..

Veeva Systems Inc. (VEEV) Investor Outlook: Analyzing Growth Potential with a 53.87% Upside

Veeva Systems Inc. (NYSE: VEEV) stands as a formidable player in the healthcare sector, particularly within the health information services industry. With a market capitalization of..

Novartis AG (NVS) Stock Analysis: Balancing High Dividend Yield with Modest Growth Prospects

As a titan in the healthcare sector, Novartis AG (NYSE: NVS) continues to capture the attention of investors with its robust market presence and a market..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Potential 55.91% Upside in the Biotech Sector

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology industry, has captured investor attention with a compelling potential upside of 55.91%, according to analyst consensus...

argenx SE (ARGX) Stock Analysis: Exploring a 15.47% Potential Upside in the Biotech Sector

argenx SE (NASDAQ: ARGX), a Netherlands-based biotechnology company, stands as a compelling player in the healthcare sector, boasting a market cap of $55.84 billion. Specializing in..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a 11.34% Potential Upside Amid Strong Buy Ratings

AbbVie Inc. (NYSE: ABBV), a leader in the healthcare sector, continues to capture investor attention with its robust portfolio and promising financial outlook. Headquartered in North..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 31.52% Potential Upside in the Healthcare Market

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling opportunity for investors seeking..

Bristol-Myers Squibb (BMY) Stock Analysis: Exploring a 10.41% Upside in the Healthcare Giant

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to capture investor interest with its robust pipeline of biopharmaceutical products. With a market..

Abbott Laboratories (ABT) Stock Analysis: Navigating a 32% Potential Upside with Strong Buy Ratings

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, has long been a cornerstone for investors seeking a blend of stability and growth. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds